Free Trial
NASDAQ:XOMA

XOMA Royalty (XOMA) Stock Price, News & Analysis

XOMA Royalty logo
$26.11 -0.23 (-0.87%)
Closing price 07/2/2025 04:00 PM Eastern
Extended Trading
$26.10 0.00 (-0.02%)
As of 07/2/2025 04:01 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About XOMA Royalty Stock (NASDAQ:XOMA)

Key Stats

Today's Range
$25.53
$26.91
50-Day Range
$23.04
$27.59
52-Week Range
$18.35
$35.00
Volume
69,261 shs
Average Volume
35,049 shs
Market Capitalization
$312.54 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$69.50
Consensus Rating
Buy

Company Overview

XOMA Royalty Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
89th Percentile Overall Score

XOMA MarketRank™: 

XOMA Royalty scored higher than 89% of companies evaluated by MarketBeat, and ranked 121st out of 940 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    XOMA Royalty has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 2 buy ratings, no hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    XOMA Royalty has only been the subject of 2 research reports in the past 90 days.

  • Read more about XOMA Royalty's stock forecast and price target.
  • Earnings Growth

    Earnings for XOMA Royalty are expected to grow in the coming year, from ($1.41) to ($0.55) per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of XOMA Royalty is -22.70, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of XOMA Royalty is -22.70, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    XOMA Royalty has a P/B Ratio of 3.76. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

  • Read more about XOMA Royalty's valuation and earnings.
  • Percentage of Shares Shorted

    1.54% of the float of XOMA Royalty has been sold short.
  • Short Interest Ratio / Days to Cover

    XOMA Royalty has a short interest ratio ("days to cover") of 4.2.
  • Change versus previous month

    Short interest in XOMA Royalty has recently decreased by 11.49%, indicating that investor sentiment is improving significantly.
  • Dividend Yield

    XOMA Royalty does not currently pay a dividend.

  • Dividend Growth

    XOMA Royalty does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    1.54% of the float of XOMA Royalty has been sold short.
  • Short Interest Ratio / Days to Cover

    XOMA Royalty has a short interest ratio ("days to cover") of 4.2.
  • Change versus previous month

    Short interest in XOMA Royalty has recently decreased by 11.49%, indicating that investor sentiment is improving significantly.
  • News Sentiment

    XOMA Royalty has a news sentiment score of 0.68. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.90 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 7 news articles for XOMA Royalty this week, compared to 2 articles on an average week.
  • Insider Buying vs. Insider Selling

    In the past three months, XOMA Royalty insiders have sold 1,674.86% more of their company's stock than they have bought. Specifically, they have bought $636,300.00 in company stock and sold $11,293,460.00 in company stock.

  • Percentage Held by Insiders

    Only 9.10% of the stock of XOMA Royalty is held by insiders.

  • Percentage Held by Institutions

    95.92% of the stock of XOMA Royalty is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about XOMA Royalty's insider trading history.
Receive XOMA Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for XOMA Royalty and its competitors with MarketBeat's FREE daily newsletter.

XOMA Stock News Headlines

XOMA Royalty to Buy Turnstone Biologics
A new rule goes live in July — and the banks are quietly cashing in
A little-known regulation quietly goes into effect this July. And it's already being exploited by Wall Street and the Big Banks… It gives them the green light to treat a certain tangible asset as equivalent to cold, hard cash. Not stocks. Not real estate. And definitely not the U.S. dollar. We're talking about something they don't want you to notice — because the fewer people who act on this, the better it is for them.
XOMA Corp - 8.375% DP PFD B declares $0.5234 dividend
See More Headlines

XOMA Stock Analysis - Frequently Asked Questions

XOMA Royalty's stock was trading at $26.28 at the beginning of 2025. Since then, XOMA shares have decreased by 0.6% and is now trading at $26.11.
View the best growth stocks for 2025 here
.

XOMA Royalty Corporation (NASDAQ:XOMA) issued its quarterly earnings results on Tuesday, May, 13th. The biotechnology company reported $0.06 earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.26) by $0.32. The biotechnology company had revenue of $15.91 million for the quarter, compared to the consensus estimate of $6.75 million. XOMA Royalty had a negative net margin of 13.04% and a negative trailing twelve-month return on equity of 12.43%.

Shares of XOMA stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that XOMA Royalty investors own include American Water Works (AWK), Waste Connections (WCN), AU Optronics (AUOTY), The RMR Group (RMR), Voyager Therapeutics (VYGR), DiamondRock Hospitality (DRH) and iShares Micro-Cap ETF (IWC).

Company Calendar

Last Earnings
5/13/2025
Today
7/02/2025
Next Earnings (Estimated)
8/12/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED - BIOMED/GENE
Sub-Industry
Biotechnology
Current Symbol
NASDAQ:XOMA
Employees
10
Year Founded
1981

Price Target and Rating

Average Stock Price Target
$69.50
High Stock Price Target
$104.00
Low Stock Price Target
$35.00
Potential Upside/Downside
+166.2%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
2 Analysts

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$13.82 million
Pretax Margin
-19.85%

Debt

Sales & Book Value

Annual Sales
$28.49 million
Price / Cash Flow
N/A
Book Value
$6.95 per share
Price / Book
3.76

Miscellaneous

Free Float
10,878,000
Market Cap
$312.54 million
Optionable
Optionable
Beta
0.93

Social Links

The 10 Best AI Stocks to Own in 2025 Cover

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report

This page (NASDAQ:XOMA) was last updated on 7/3/2025 by MarketBeat.com Staff
From Our Partners